WallStreetZenWallStreetZen

NASDAQ: BVS
Bioventus Inc Stock Ownership - Who owns Bioventus?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark Leonard SingletonSVP CFO2026-03-208,091$8.64
$69.91kSell
Katrina J. ChurchSVP Chief Compliance Officer2026-03-131,501$8.62
$12.94kSell
Katrina J. ChurchSVP Chief Compliance Officer2026-03-131,521$8.62
$13.11kSell
Anthony DadamioSVP General Counsel2026-03-133,861$8.62
$33.28kSell
Robert E. ClaypoolePresident and CEO2026-03-1314,553$8.62
$125.45kSell
Anthony DadamioSVP General Counsel2026-03-133,802$8.62
$32.77kSell
Mark Leonard SingletonSVP CFO2026-03-135,865$8.62
$50.56kSell
Michelle McMurryheathDirector2026-03-1112,000$8.79
$105.44kSell
Anthony DadamioSVP General Counsel2026-02-156,327$8.27
$52.32kSell
Mark Leonard SingletonSVP CFO2026-02-159,429$8.27
$77.98kSell

1 of 2

BVS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Smith Nephew PLC19.88%16,534,814$151.46MInsider
Juniper Investment Company LLC15.84%13,168,697$120.63MInsider
Martin P. Sutter15.76%13,106,565$120.06MInsider
Ew Healthcare Partners Acquisition Fund LP15.66%13,021,324$119.28MInsider
Essex Woodlands Management Inc15.66%13,021,324$119.28MInstitution
John A. Bartholdson8.44%7,018,977$64.29MInsider
Juniper Investment Company LLC8.35%6,939,357$63.56MInstitution
Nantahala Capital Management LLC7.27%6,047,403$55.39MInstitution
Spindletop Healthcare Capital LP4.70%3,906,395$35.78MInsider
David J. Parker3.91%3,255,332$29.82MInsider

1 of 3

BVS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS38.43%61.57%Net SellingNet Selling
IART66.31%33.69%Net SellingNet Selling
CBLL72.35%27.65%Net SellingNet Selling
INMD53.90%11.97%
AVNS95.47%4.53%Net BuyingNet Selling
View Top Medical Device Stocks

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 60.37% institutional shareholders, 96.73% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 19.88% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $153.11M.

If you're new to stock investing, here's how to buy Bioventus stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.